FDA Investigator

Joseph D Doleski

Latest inspection on record: Raritan, United States, November 2010 · records back to 2008

FDA inspection record · Last updated July 12, 2026

Overview

  • 7 inspections across 7 sites are on record.
  • 0 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2010-11-12.

At a glance

Inspections

7

Sites

7

Observations

0

Career since

Feb 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Ortho-Clinical Diagnostics, Inc.12 Nov 2010On file
Merck Sharp & Dohme LLC14 May 2010On file
Kamada - Production Plant11 Feb 2010On file
Seqirus Vaccines Limited21 Aug 2009On file
Northfield Laboratories Inc20 Feb 2009

Sites inspected

Ortho-Clinical Diagnostics, Inc.Raritan, United States1 insp.
Merck Sharp & Dohme LLCDurham, United States1 insp.
Kamada - Production PlantMP Negev, Israel1 insp.
Seqirus Vaccines LimitedLiverpool, United Kingdom1 insp.
Northfield Laboratories IncMt Prospect, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Joseph D Doleski's inspection record

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site